ANRO Deadline: Rosen Law Firm Urges Alto Neuroscience, Inc. (NYSE: ANRO) Stockholders to Contact the Firm for Information About Their Rights

Group 1 - A class action has been filed on behalf of shareholders of Alto Neuroscience, Inc. (NYSE: ANRO) [1] - The class action pertains to purchases of common stock made during Alto's initial public offering on or about February 2, 2024, and securities purchased between February 2, 2024, and October 22, 2024 [1] - Alto Neuroscience is identified as a clinical-stage biopharmaceutical company based in the U.S. [1]